Chinese pharmaceutical e-commerce company Miaoshou Doctor has secured an RMB500 million (US$72.77 million) series C+ round of financing led by Chinese private equity firm Starquest Capital, with the participation of investors like Sequoia Capital China, Sequoia confirmed to China Money Network on Monday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?